Journal of Enzyme Inhibition and Medicinal Chemistry · 2008 · 24 citations · 13 references
MedicineMolecular BiologyPharmacologyCancer PharmacologyChemotherapyMolecular OncologyCytotoxicity AssessmentCytotoxicity EvaluationDna DamageTopoisomerase InhibitorsAnticancer ActivityAnticancer ChemotherapyCytotoxicity AssaysDna Topoisomerase I InhibitionKetonesT Cell CytotoxicityTopoisomerase I Inhibitors
Chalcones (1,3-diaryl-2-propen-1-ones) are alpha, beta-unsaturated ketones with cytotoxic and anticancer properties. Several reports have shown that compounds with cytotoxic properties may also interfere with DNA topoisomerase functions. Five derivatives of 4'-hydroxychalcones were examined for cytotoxicity against transformed human T (Jurkat) cells as well as plasmid supercoil relaxation experiments using mammalian DNA topoisomerase I. The compounds were 3-phenyl-1-(4'-hydroxyphenyl)-2-propen-1-one (I), 3-(p-methylphenyl)-1-(4'-hydroxyphenyl)-2-propen-1-one (II), 3-(p-methoxyphenyl)-1-(4'-hydroxyphenyl)-2-propen-1-one (III), 3-(p-chlorophenyl)-1-(4'-hydroxyphenyl)-2-propen-1-one (IV), and 3-(2- thienyl)-1-(4'-hydroxyphenyl)-2-propen-1-one (V). The order of the cytotoxicity of the compounds was; IV > III > II > I > V. Compound IV, had the highest Hammett and log P values (0.23 and 4.21, respectively) and exerted both highest cytotoxicity and strongest DNA topoisomerase I inhibition. Compounds I and II gave moderate interference with the DNA topoisomerase I while III & V did not interfere with the enzyme.
13
The Chemistry of Chalcones and Related Compounds
Dervilla M. X. Donnelly · Phytochemistry · 1982 · 332 citations
DNA topoisomerases as targets for anticancer drugs
Z. Topcu · Journal of Clinical Pharmacy and Therapeutics · 2001 · 149 citations · Full text
Curcumin as a DNA Topoisomerase II Poison
Carmen Martı́n-Cordero, Miguel López‐Lázaro, Marina Gálvez et al. · Journal of Enzyme Inhibition and Medicinal Chemistry · 2003 · 106 citations · Full text
Medicine, Oncology, Pharmacology +14
Degradation and Inactivation of Antitumor Drugs
John A. Benvenuto, Thomas H. Connor, David Monteith et al. · Journal of Pharmaceutical Sciences · 1993 · 94 citations
Medicine, Cancer Biology, Oncology +12